🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

Global - North America Archived • August 7, 2026 • 2 views
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
Source: NPR News | https://feeds.npr.org/1001/rss.xml - Read Original
"Camping the Easyway"
"Free Quote Today"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"House Plans for Structures New and Old"
"Network Cable Repairs from $29"